Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Will Combine Two Units Into One

Click here for an updated version of this story.

 

NEW YORK, Oct. 29 - PerkinElmer today said it will combine its Life Sciences and Analytical Instruments business units into a new division called Life and Analytical Sciences.

Peter Coggins, formerly president of the Life Sciences unit, will be president of the new organization, which takes shape "immediately." Stephen DeFalco, the current president of Analytical Instruments, will help with the transition through the end of the year.

 

It was not immediately clear whether he will stay on in the new unit. It was also not immediately know whether the new business will retain all of the staff that currently works for Life Sciences and Analytical Instruments. The combined unit has approximately $1 billion in revenue, more than 2,000 sales, service, and applications employees, and an annual R&D budget of around $65 million, according to PerkinElmer.

The Life and Analytical Sciences will be headquartered in Boston, and PerkinElmer will "continue to maintain a significant presence" in Shelton, Conn., former headquarters of the Analytical Instruments unit.

The new unit "will enable PerkinElmer to provide a single, unified face" to its customers and "bring greater resources to our analytical customers," said Gregory Summe, chairman and CEO of PerkinElmer. "It also enables us to better leverage our R&D investment, global sales and service network, and operational capabilities."

 

Click here for more information.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.